The Patent Finder

Implantable Device for Sustained Release of a Macromolecular Drug Compound (2019)

Celanese Eva Performance Polymers LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,690,806Implantable Device for Sustained Release of a Macromolecular Drug Compound
In force
 · High confidence
UsedRemaining
Celanese Eva Performance Polymers LLCIn forceHigh confidence
US 12,108,225Implantable Device for Sustained Release of a Macromolecular Drug Compound
In force
 · High confidence
Celanese EVA Performance Polymers LLCIn forceHigh confidence
Application 18/810,589Implantable Device for Sustained Release of a Macromolecular Drug Compound
Pending
Not granted
Celanese EVA Performance Polymers LLCPendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Celanese Eva Performance Polymers LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited